期刊文献+

克隆探针技术发现类风湿性关节炎新型抗原 被引量:1

Research on a Novel Autoantigen in Rheumatoid Arthritis
下载PDF
导出
摘要 类风湿性关节炎(RA)是一种病因尚未明了的全身性自身免疫性疾病。近年来,在RA的治疗方面国际科研界有了较大的进展,但目前仍然很少有新的自身抗原被发现。本课题首次运用患者关节滑膜液中的抗体作为探针,提取RNA,进行cDNA基因库免疫筛选。结果发现新型自身抗原cDNA克隆,因其与RBP1有36.5%的氨基酸序列相同,因此命名RBP1like Protein(Rbik),此自身抗原的发现有可能为类风湿性关节炎的实验诊断和治疗提供新的可能指标和靶点。 Rheumatoid arthritis (RA) is an autoimmune disease characterized by long-term in- flammation and resultant destruction of multiple joints. In joint spaces of patients with rheumatoid arthritis (RA), persistently presented antigens appear to play a major role in sustained in- flammation by continuously stimulating T and B cells. Synovium seems to supply most of such antigens. We cloned RBPl-like protein from synovial tissue, named Rbik,as an autoantigen in RA.Rbik has 36.5% homology with retinoblastoma binding protein 1 (RBP1) which associates with retinoblastoma (RB) tumor suppressor protein and is thought to thereby modulate the gene repression activity of RB. we report that analysis between RA and the new autoantibodies to RBPi-like Protein(Rbik).
出处 《湖北民族学院学报(医学版)》 2016年第1期8-10,共3页 Journal of Hubei Minzu University(Medical Edition)
基金 国家自然科学基金项目(81560732) 西藏自治区自然科学基金项目(2015ZR-13-18) 西藏自治区高校青年教师创新支持计划项目(QC2015-61)
关键词 类风湿性关节炎 自身抗原 RBP1 克隆 免疫 RA autoantigen RBP1 cloning immunology
  • 相关文献

参考文献12

  • 1Kim GW, Lee NR, Pi RH, et al. IL-6 inhibitors for treat- ment of rheumatoid arthritis : past, present, and future [ J ]. Arch Pharm Res,2015,38(5) :75-84.
  • 2Venkatesha SH, Dudics S, Acharya B, et al.Cytokine-mod- ulating strategies and newer cytokine targets for arthritis therapy[J] Ant J Mol Sci,2014, 16( 1 ) :887-906.
  • 3Tomasiewicz B, Hurkacz M ,Jarzibowski J ,et al.Welfare as the goal of the analgesic pharmacotherapy accompanying biological treatment in patients with rheumatoid arthritis and ankylosing spondyhtis [ J ]. Pol Merkur Lekarski, 2014,37(221 ) :274-279.
  • 4Roubille C, Richer V, Starnino T. Response to :' Potential harmful cardiovascular effects of glucocorticoids should not be underestimated in RA' by Boers[J].Ann Rheum Dis,2015(3) :2015-2074.
  • 5Brown PM, Isaacs JD. Rheumatoid Arthritis : an Evolution- ary Force in Biologics [ J ]. Curt Pharm Des, 2015, 21 (17) :2 170-2 178.
  • 6Nogueira L, Cornillet M, Singwe-Ngandeu M, et al. In Black Africans with Rheumatoid Arthritis, ACPA recog- nize eitrullinated fibrinogen and the derived peptides ct36 -50Cit38,42 and 1360-74Cit60, 72, 74, like in Cauca- sians[J]. Clin Immunol,2014,152(12) :58-64.
  • 7Hair M J, Sande MG, Ramwadhdoebe TH, et al. Features of the synovium of individuals at risk of developing rheu- matoid arthritis:implications for understanding preclinical rheumatoid arthritis [ J ]. Arthritis Rheumatol, 2014, 66 (3) :13-22.
  • 8Jin H, Arase N, Hirayasu K, et al. Autoantibodies to IgG! HLA class II complexes are associated with rheumatoid arthritis susceptibility [ J ]. Proc Natl Acad Sci USA, 2014,111 (10) :87-92.
  • 9Verheijden GF, Rijnders AW, Bos E, et al. Human carti- lage glycoprotein-39 as a candidate autoantigen in rheu- matoid arthritis [ J ]. Zhonghua Nei Ke Za Zhi, 2004, 43 (12) :28-31.
  • 10Mimori T, Suganuma K, Tanami Y, et al. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-de- pendent neutral protease, calpain)in systemic rheumatic diseases[ J].Proc Natl Acad Sci USA, 1995,92(16) :67 -71.

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部